Comparison of geroprotection techniques in 110 people
How the study was set up
A comparative report followed 110 people receiving several approaches, including a combined Pinealon/Vesugen preparation.
What the researchers measured
Biological-age indicators, biochemical and immunological measures, and clinical condition were compared.
How to read this evidence
Researchers observed people or measured naturally occurring peptide levels. Associations do not show that administering the peptide caused a benefit.
Results in context
A combined preparation prevents isolation of Pinealon's contribution. Favorable scores and selected safety markers do not establish a lifespan benefit or general safety.
What this does not establish
A combined regimen cannot isolate Pinealon's effect; surrogate indicators are not demonstrated extension of lifespan or healthy lifespan.
Publication & source
Why this paper is included
A human report examined combined Pinealon and Vesugen treatment; this does not isolate Pinealon effects.